Semaglutide is a peptide that belongs to a class of medications known as glucagon-like peptide-1 receptor agonists or better known as GLP-1 RAs. It mimics the GLP-1 hormone which is released in the gut as a response to eating.
One of the roles of GLPs is to prompt the body to produce more insulin which is responsible for reducing blood sugar. This medication has been used for more than 10 years to treat type 2 diabetes.
GLP1s in higher amounts also act on portions of the brain that suppress appetite and signal satiety (feeling full). GLP-1s also slows the rate at which your stomach empties which leads to an increase in the feeling of fullness. When used in conjunction with diet and exercise, it can lead to significant weight loss which in turn reduces the incidence of diabetes, hypertension and reduces the risk of cancer.
It is important to use compounded semaglutide under the supervision of a healthcare professional. The benefits and risks of this medication should be carefully weighed on an individual basis. For lasting weight loss results, it is recommended to adopt a holistic approach that includes both medication and lifestyle changes.
Tirzepatide is very similar to Semaglutide. It belongs to the same class of medications (GLP-1 RAs) and is used for the treatment of Type 2 Diabetes mellitus as well as weight loss. This drug also activates glucose-dependent insulinotropic polypeptide (GIP) as well as GLP1.